-
1Academic Journal
المؤلفون: Abdullah Althemery, Abdulrahman Alturaiki, Rawan Alanazi, Nawal Almotairi, Manal Aljohani, Khalefa Althiab, Abdullah Alfaifi
المصدر: Clinical Epidemiology and Global Health, Vol 31, Iss , Pp 101880- (2025)
مصطلحات موضوعية: Hepatitis C virus, Genotypes, Antiviral agents, Paritaprevir, Sofosbuvir, Public aspects of medicine, RA1-1270
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: Badr M. Aljarallah
المصدر: Journal of Pharmacy and Bioallied Sciences, Vol 16, Iss Suppl 3, Pp S2224-S2227 (2024)
مصطلحات موضوعية: chronic kidney disease, genotype 4, hepatitis c virus, ombitasvir, paritaprevir, Pharmacy and materia medica, RS1-441, Analytical chemistry, QD71-142
وصف الملف: electronic resource
-
3Academic Journal
المؤلفون: Jajula, Naga Venkata Indira Devi1, Pawar, A. Krishnamanjari2, 1
المصدر: Research Journal of Pharmacy and Technology 16(5):2306-2310. 2023
-
4Academic Journal
المؤلفون: Pappula, Nagaraju1, 1, Narla, Divya2, 3
المصدر: Research Journal of Pharmacy and Technology 15(3):1307-1312. 2022
-
5Academic Journal
المؤلفون: Jiuhong Zha, Qi Jiang, Betty B. Yao, Daniel E. Cohen, David C. Carter, Rajeev M. Menon
المصدر: Pharmacology Research & Perspectives, Vol 10, Iss 6, Pp n/a-n/a (2022)
مصطلحات موضوعية: CYP3A inhibitor, dasabuvir, everolimus, hepatitis C, ombitasvir, paritaprevir, Therapeutics. Pharmacology, RM1-950
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2052-1707
-
6Academic Journal
المؤلفون: Nahla Mohamed Teama, Waleed Anwar Abdel-Mohsen, Ossama Ashraf Ahmed, Sarah Mohamed El Sayed, Ahmed Mohamed ElGhandour
المصدر: Egyptian Liver Journal, Vol 11, Iss 1, Pp 1-8 (2021)
مصطلحات موضوعية: Ombitasvir, Paritaprevir, Ritonavir, Ribavirin chronic hepatitis C, Hemodialysis, Surgery, RD1-811, Diseases of the digestive system. Gastroenterology, RC799-869
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2090-6226
-
7Academic Journal
المؤلفون: Yusheng Jie, Chaoshuang Lin, Jing Yuan, Zhixin Zhao, Yujuan Guan, Yuanping Zhou, Xiaohui Zhou, Bihui Zhong, Yinong Ye, Lihua Zhang, Ling Tao, Jianping Li, Xiaohong Zhang, Yutian Chong
المصدر: Liver Research, Vol 4, Iss 3, Pp 153-158 (2020)
مصطلحات موضوعية: Hepatitis C virus (HCV), Direct-acting antiviral agent (DAA), Real-world research, Ombitasvir (OBT), Paritaprevir (PTV), Ritonavir, Diseases of the digestive system. Gastroenterology, RC799-869
وصف الملف: electronic resource
-
8Academic Journal
المؤلفون: Bal T., Önlen Y., Çabalak M., Öztoprak N.Ç., Sarı N.D., Kurtaran B., Şenateş E.
مصطلحات موضوعية: chronic hepatitis C, Age, direct-acting antiviral agents, elderly, Turkey, antivirus agent, dasabuvir plus ombitasvir plus paritaprevir plus ritonavir, ledipasvir plus sofosbuvir, ribavirin, sofosbuvir, adult, aged, anemia, angioneurotic edema, Article, bleeding, cohort analysis, constipation, decompensated liver cirrhosis, demography, drug efficacy, drug safety, drug withdrawal, dyspnea, fatigue, female, groups by age, headache, Hepatitis C virus genotype 1, human
Relation: Turkish Journal of Gastroenterology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/11454/80027; https://doi.org/10.5152/tjg.2022.21271; 33; 10; 862; 873
-
9Academic Journal
المؤلفون: Richard S. Hong (9943335), Rajni Miglani Bhardwaj (11553257), Rodger Henry (1392976), Alessandra Mattei (1796989), Moiz Diwan (6900881), Albert Thomas (11272199), Gerald D. Danzer (4965586), Ahmad Y. Sheikh (2336962)
مصطلحات موضوعية: Biophysics, Biochemistry, Physiology, Evolutionary Biology, Ecology, Cancer, Inorganic Chemistry, Chemical Sciences not elsewhere classified, strong intermolecular interactions, membered macrocyclic ring, intramolecular hydrogen bond, contains stable channels, 5 mol equiv, entropic stabilization occurs, distinct hybrid hydrates, paritaprevir drug substance, exhibit hybrid features, regulatory controls paritaprevir, regulatory context, nonstoichiometric hydrates, enthalpic stabilization, unique chameleonic, testing within, state features, significantly lowers, partially compensated, hydration state, generation direct, energetic advantage, conformational energy
-
10Conference
المساهمون: Aygen, Bilgehan, Demirturk, Nese, Yildiz, Orhan, Celen, Mustafa Kemal, Celik, Ilhami, Barut, Sener, Ural, Onur, Batirel, Ayse, Mistik, Resit, Simsek, Funda, Asan, Ali, Ersoz, Gulden, Turker, Nesrin, Bilgin, Huseyin, Kinikli, Sami, Karakecili, Faruk, Zararsiz, Gokmen
مصطلحات موضوعية: Chronic hepatitis C, HCV genotypes 1 and 4, ombitasvir, paritaprevir, dasabuvir, real-world effectiveness, SUSTAINED VIROLOGICAL RESPONSE, RITONAVIR PLUS RIBAVIRIN, ANTIVIRAL THERAPY, HCV, ABT-450/R-OMBITASVIR, MULTICENTER, PARITAPREVIR/RITONAVIR/OMBITASVIR, RETREATMENT
Relation: TURKISH JOURNAL OF GASTROENTEROLOGY; https://hdl.handle.net/11424/263985; WOS:000535263200004
-
11Academic Journal
المساهمون: Konya, Petek
مصطلحات موضوعية: Hemodialysis, Hepatitis C, Ombitasvir, Paritaprevir, Dasabuvir
وصف الملف: application/pdf
Relation: Flora İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.5578/flora.20219620; https://hdl.handle.net/20.500.12933/1117; 26; 736; 741
-
12Academic Journal
المؤلفون: Verhaz Antonija, Kezić Zdravka, Stojiljković Miloš P., Škrbić Ranko
المصدر: Scripta Medica, Vol 50, Iss 2, Pp 77-81 (2019)
مصطلحات موضوعية: hepatitis c virus, ombitasvir, paritaprevir, ritonavir, dasabuvir, ribavirin, Medicine
وصف الملف: electronic resource
-
13Academic Journal
المؤلفون: Haruki Uojima, Shuzo Kobayashi, Hisashi Hidaka, Takeshi Kinbara, Tomoaki Fujikawa, Tsuyoshi Nakayama, Hiroki Yamanoue, Takayuki Kanemaru, Tohru Hashimotoh, Ji Hyun Sung, Makoto Kako, Wasaburo Koizumi
المصدر: Annals of Hepatology, Vol 18, Iss 1, Pp 109-115 (2019)
مصطلحات موضوعية: Elderly patients, hepatitis C virus, ombitasvir, paritaprevir, ritonavir, Specialties of internal medicine, RC581-951
وصف الملف: electronic resource
-
14Academic Journal
المؤلفون: Jan Sperl, Miluse Kreidlova, Dusan Merta, Klara Chmelova, Renata Senkerikova, Sona Frankova
المصدر: Kidney & Blood Pressure Research, Vol 43, Iss 2, Pp 594-605 (2018)
مصطلحات موضوعية: Ombitasvir, Paritaprevir, Dasabuvir, Hepatitis C, Genotype 1, Haemodialysis, Dermatology, RL1-803, Diseases of the circulatory (Cardiovascular) system, RC666-701, Diseases of the genitourinary system. Urology, RC870-923
وصف الملف: electronic resource
-
15Academic Journal
المؤلفون: Varón A., Santos L., Tapias M., Cáez C., Marín J.I., Santos Ó., Garzón M., Beltrán Ó., Gómez-Aldana A., Yepes I.J., Rondón M., Rosselli D.
المصدر: instname:Universidad del Rosario
مصطلحات موضوعية: Alanine aminotransferase, Antivirus agent, Aspartate aminotransferase, Asunaprevir, Biological marker, Daclatasvir, Daclatasvir plus ribavirin, Daclatasvir plus simeprevir, Dasabuvir, Ledipasvir, Ledipasvir plus ribavirin, Ledipasvir plus sofosbuvir, Ombitasvir, Paritaprevir, Paritaprevir plus ribavirin, Ribavirin, Ribavirin plus sofosbuvir, Ritonavir, Simeprevir, Sofosbuvir, Unclassified drug, Virus rna, Adult, Aged, Alanine aminotransferase blood level, Anemia, Anxiety disorder, Article, Aspartate aminotransferase blood level, Asthenia
وصف الملف: application/pdf
-
16Academic Journal
المؤلفون: Asrul Akmal Shafie, Muhammad Radzi Abu Hassan, Siew Chin Ong, Suchin Virabhak, Yuri Sanchez Gonzalez
مصطلحات موضوعية: cost effectiveness, analysis, Ombitasvir, Paritaprevir, Dasabuvir, Ritonavir, Ribavirin, Regimen, Patients, Chronic, Hepatitis C, Virus, Genotype, Malaysia
Relation: https://zenodo.org/communities/crc_icr_nih; https://doi.org/10.1016/j.vhri.2019.09.005; oai:zenodo.org:4311469
-
17Academic Journal
المصدر: Infectious Diseases; No. 2 (2019); 15-21 ; Інфекційні хвороби; № 2 (2019); 15-21 ; 2414-9969 ; 1681-2727 ; 10.11603/1681-2727.2019.2
مصطلحات موضوعية: chronic hepatitis C, antiviral treatment, sofosbuvir, ombitasvir, paritaprevir, dasabuvir, хронічний гепатит С, противірусне лікування, софосбувір, омбітасвір, паритапревір, дасабувір
وصف الملف: application/pdf
Relation: https://ojs.tdmu.edu.ua/index.php/inf-patol/article/view/10321/9874; https://ojs.tdmu.edu.ua/index.php/inf-patol/article/view/10321; https://repository.tdmu.edu.ua//handle/123456789/14324
-
18Academic Journal
المؤلفون: Patel, S.V., Jayaweera, D.T., Althoff, K.N., Eron, J.J., Radtchenko, J., Mills, A., Moyle, G., Santiago, S., Sax, P.E., Gillman, J., Mounzer, K., Elion, R.A., Huhn, G.D.
المصدر: PLoS ONE, 15(2)
مصطلحات موضوعية: ledipasvir plus sofosbuvir, elbasvir plus grazoprevir, alanine aminotransferase, aspartate aminotransferase, sofosbuvir, ribavirin, sofosbuvir plus velpatasvir, daclatasvir, peginterferon, dasabuvir plus ombitasvir plus paritaprevir plus ritonavir, simeprevir
Relation: https://doi.org/10.17615/5qhn-ad14; https://cdr.lib.unc.edu/downloads/6682x9962?file=thumbnail; https://cdr.lib.unc.edu/downloads/6682x9962
-
19Academic Journal
المؤلفون: Hussaini T
المصدر: Hepatic Medicine: Evidence and Research, Vol 2016, Iss Issue 1, Pp 61-68 (2016)
مصطلحات موضوعية: Hepatitis C, Paritaprevir, Ombitasvir, Dasabuvir, 3D Regimen, Diseases of the digestive system. Gastroenterology, RC799-869
وصف الملف: electronic resource
-
20Academic Journal
المؤلفون: Itkonen, Matti K., Tornio, Aleksi, Lapatto-Reiniluoto, Outi, Neuvonen, Mikko, Neuvonen, Pertti J., Niemi, Mikko, Backman, Janne T.
المساهمون: HUSLAB, Department of Clinical Pharmacology, University of Helsinki, Clinicum, Medicum, Janne Backman / Principal Investigator
مصطلحات موضوعية: DRUG-DRUG INTERACTION, ACTING ANTIVIRAL REGIMEN, PLASMA-CONCENTRATIONS, MARKEDLY INCREASES, CYTOCHROME-P450 3A, PLUS DASABUVIR, PHARMACOKINETICS, OMBITASVIR, PARITAPREVIR/RITONAVIR, PHARMACODYNAMICS, Pharmacy, Biomedicine
وصف الملف: application/pdf
Relation: The study was supported by grants from the Academy of Finland (Grant decision 278123, 2014), and by State funding for university-level health research (Hospital District of Helsinki and Uusimaa, Finland).; Itkonen , M K , Tornio , A , Lapatto-Reiniluoto , O , Neuvonen , M , Neuvonen , P J , Niemi , M & Backman , J T 2019 , ' Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel ' , Clinical Pharmacology and Therapeutics , vol. 105 , no. 1 , pp. 219-228 . https://doi.org/10.1002/cpt.1099; ORCID: /0000-0002-9577-2788/work/53182851; ORCID: /0000-0003-3631-9411/work/53184222; ORCID: /0000-0001-5713-5692/work/53184734; http://hdl.handle.net/10138/296443; 1d087619-e813-400a-89e3-e7e65d3bf39d; 85052407398; 000454618200031
الاتاحة: http://hdl.handle.net/10138/296443